Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
9.12
+0.09 (1.00%)
At close: Jul 17, 2026, 4:00 PM EDT
9.00
-0.12 (-1.32%)
After-hours: Jul 17, 2026, 7:31 PM EDT

Turn Therapeutics Statistics

Total Valuation

TTRX has a market cap or net worth of $271.67 million. The enterprise value is $266.46 million.

Market Cap271.67M
Enterprise Value 266.46M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, after market close.

Earnings Date Aug 10, 2026
Ex-Dividend Date n/a

Share Statistics

TTRX has 29.79 million shares outstanding. The number of shares has increased by 5.93% in one year.

Current Share Class 29.79M
Shares Outstanding 29.79M
Shares Change (YoY) +5.93%
Shares Change (QoQ) +3.69%
Owned by Insiders (%) 58.79%
Owned by Institutions (%) 2.68%
Float 10.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 44.41
P/TBV Ratio 52.27
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.98.

Current Ratio 2.23
Quick Ratio 2.19
Debt / Equity 0.98
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -129.17% and return on invested capital (ROIC) is -79.70%.

Return on Equity (ROE) -129.17%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) -79.70%
Return on Capital Employed (ROCE) -56.94%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.92M
Employee Count2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 6.21
200-Day Moving Average n/a
Relative Strength Index (RSI) 65.66
Average Volume (20 Days) 112,177

Short Selling Information

The latest short interest is 38,506, so 0.13% of the outstanding shares have been sold short.

Short Interest 38,506
Short Previous Month 30,684
Short % of Shares Out 0.13%
Short % of Float 0.36%
Short Ratio (days to cover) 0.65

Income Statement

Revenue n/a
Gross Profit -974,595
Operating Income -7.69M
Pretax Income -3.84M
Net Income -3.84M
EBITDA -7.64M
EBIT -7.69M
Earnings Per Share (EPS) -$0.14
Full Income Statement

Balance Sheet

The company has $11.22 million in cash and $6.01 million in debt, with a net cash position of $5.21 million or $0.17 per share.

Cash & Cash Equivalents 11.22M
Total Debt 6.01M
Net Cash 5.21M
Net Cash Per Share $0.17
Equity (Book Value) 6.12M
Book Value Per Share 0.21
Working Capital 6.32M
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.90M
Capital Expenditures n/a
Depreciation & Amortization 54,775
Net Borrowing 6.72M
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TTRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.93%
Shareholder Yield -5.93%
Earnings Yield -1.41%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a